Published Paper Details:

Abstract: Pharmacovigilance involves monitoring how medicines perform once they are administered to actual patients. Its main aim is to identify unforeseen effects, comprehend their causes, and prevent damage. Although the idea has been informally recognized for many years, it became significantly important after several tragedies related to medications underscored the need for enhanced safety systems. Today, it is a crucial aspect of healthcare that guarantees the advantages of a drug surpass its risks. The goal of pharmacovigilance is to safeguard individuals from adverse drug effects, promote safe prescribing, and inform decisions taken by health authorities. Since clinical trials are conducted with a limited number of participants under controlled circumstances, many side effects only emerge when larger populations start utilizing the medication. Continuous monitoring of safety is crucial. Beyond its scientific significance, pharmacovigilance inherently comes with an ethical obligation--patients have the right to receive treatments that are effective and safe. Adverse drug reactions (ADRs) are undesired effects that may arise after medication usage. These can vary from minor irritations to serious health issues. By monitoring these reactions, healthcare systems can recognize trends, uncover new dangers, and modify treatment guidelines as needed. Each report adds to a broader database, assisting specialists in comprehending how medications function in real-world conditions. In India, a network of monitoring centres facilitates ADR reporting, allowing healthcare professionals and the public to provide information on suspected reactions. These submissions undergo review and validation before being included in both national and international safety databases. This collective data aids global organizations in pinpointing signals and advising on safety protocols.